☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Launches
Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India
October 26, 2021
Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India
October 26, 2021
Sandoz Launches Inclunox and Inclunox HP (biosimilar- enoxaparin sodium solution) in Canada
May 17, 2021
Sandoz Launches Inclunox and Inclunox HP (biosimilar- enoxaparin sodium solution) in Canada
May 17, 2021
Amgen Launches Amgevita (biosimilar- adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases in Canada
May 5, 2021
Amgen Launches Amgevita (biosimilar- adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases in Canada
May 5, 2021
Load more...
Back to Home